Dupilumab Reduces Exacerbations and Improves Lung Function and Quality of Life in Patients with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation: The Notus Trial

DOI: 10.1055/s-0045-1804578 Publication Date: 2025-03-18T23:55:56Z